Novel functions for Type II procollagen

Connective Tissue Research

Volumn 55, Issue 1, 2014, Pages 20-25

  Sandell, Linda J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti angiogenic; Cartilage; Chondrocytes; NH2 propeptide; Type II collagen

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; NH2 PROPEPTIDE; PROCOLLAGEN; PROCOLLAGEN TYPE 2; UNCLASSIFIED DRUG;

ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE; CARTILAGE; CARTILAGE CELL; ENDOTHELIUM CELL; MOLECULE; NONHUMAN; OSTEOCLAST; PROTEIN FUNCTION; TUMOR INVASION;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CHONDROCYTES; COLLAGEN TYPE II; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROCOLLAGEN;

EID: 84892721857     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2013.867340     Document Type: Article

References (20)

1. Langer R, Brem H, Falterman K, Klein M, Folkman J. Isolations of a cartilage factor that inhibits tumor neovascularization. Science 1976;193:70-2.
2. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogeneis. J Exp Med 1971;133: 275-88.
3. Kuettner KE, Hiti J, Eisenstein R, Harper E. Collagenase inhibition by cationic proteins derived from cartilage and aorta. Biochem Biophys Res Commun 1976;72:40-6.
4. Eisenstein R, Schumacher B, Meineke C, Matijevitch B, Kuettner KE. Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice. Am J Pathol 1978;91:1-9.
5. Patra D, Sandell LJ. Antiangiogenic and anticancer molecules in cartilage. Expert Rev Mol Med 2012;14:e10. doi: 10.1017/ erm.2012.3.
6. DiMuzio MT, Tripier D, Kuettner KE. Purification and characterization of an elastase inhibitor derived from hyaline cartilage. J Rheumatol 1987;14:45-8.
7. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-4.
8. Moses MA, Langer R. Inhibitors of angiogenesis. Biotechnology (N Y) 1991;9:630-4.
9. Hiraki Y, Inoue H, Iyama K-i, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J. Identification of Chondromodulin I as a Novel Endothelial Cell Growth Inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997;272:32419-26.
10. Moses MA, Wiederschain D, Wu I, Fernandez CA, Ghazizadeh V, Lane WS, Flynn E, Sytkowski A, Tao T, Langer R. Troponin I is present in human cartilage and inhibits angiogenesis. PNAS 1999; 96:2645-50.
11. Liu N, Lapcevich RK, Underhill CB, Han Z, Gao F, Swartz G, Plum S, Zhang L, Green SJ. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res 2001;61:1022-8.
12. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 2001;33:357-69.
13. Sim BKL, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997;57:1329-34.
14. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
15. Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003;278: 4238-49.
16. Fernandes RJ, Hirohata S, Engle JM, Colige A, Cohn DH, Eyre DR, Apte SS. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 2001;276: 31502-9.
17. Ryan MC, Sandell LJ. Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem 1990; 265:10334-9.
18. Wang Z, Bryan J, Franz C, Havlioglu N, Sandell LJ. Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5). J Biol Chem 2010;285:20806-17.
19. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989;109:1817-26.
20. Hayashi S, Wang Z, Bryan J, Kobayashi C, Faccio R, Sandell LJ. The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling. Bone 2011;49:644-52.